Teva Pharmaceutical Industries Ltd (TEVA)
Teva Pharmaceutical Industries is a pharmaceutical company. Co. operates through three segments: North America, which includes the U.S. and Canada; Europe, which includes the European Union and certain other European countries; and International Markets, which includes all countries in which Co. operates other than those in Co.'s North America and Europe segments. Co.'s products include: AUSTEDO; AJOVY (anti calcitonin gene-related peptide); COPAXONE; BENDEKA and TREANDA; ProAir HFA; ProAir RespiClick; QVAR; QVAR RediHaler; ProAir Digihaler; ArmonAir Digihaler; AirDuo Digihaler; BRALTUS®; CINQAIR/CINQAERO; and AirDuo RespiClick.
Company Name: |
Teva Pharmaceutical Industries Ltd |
Website: |
www.tevapharm.com |
Sector: |
Drugs & Pharmaceuticals |
Number of ETFs Holding TEVA: |
28 |
Total Market Value Held by ETFs: |
$306.37M |
Total Market Capitalization: |
$9.79B |
% of Market Cap. Held by ETFs: |
3.13% |
|
|
March 28, 2024 4:25 AM Eastern
Buy (3.33 out of 4)
46th percentile
|
|